Pembrolizumab plus chemotherapy followed by pembrolizumab in participants in Asia with early triple-negative breast cancer: An updated subgroup analysis of the KEYNOTE-522 randomized clinical trial
Yeon Hee Park, Rina Hui, Seock-Ah Im, Jin-Hee Ahn et autres
kr, au, tw, jp, es, us, ch, de, pt, sg, gb (code pays fourni par la source)